Feasibility of a Multiplex Flow Cytometric Bead Immunoassay for Detection of Anti-Epoetin Alfa Antibodies
-
Published:2007-09
Issue:9
Volume:14
Page:1165-1172
-
ISSN:1556-6811
-
Container-title:Clinical and Vaccine Immunology
-
language:en
-
Short-container-title:Clin Vaccine Immunol
Author:
Ferbas John123, Thomas John123, Hodgson John123, Gaur Amitabh123, Casadevall Nicole123, Swanson Steven J.123
Affiliation:
1. Amgen, Inc., Thousand Oaks, California 2. BD Biosciences, San Diego, California 3. Hôpital de l'Hôtel-Dieu, Service d'Hématologie Biologique, Paris, France
Abstract
ABSTRACT
Immunogenicity profiles of recombinant therapeutic proteins are important to understand because antibodies raised against these molecules may have important clinical sequelae. The purpose of the present study was to demonstrate that a flow cytometric bead array could be used to detect clinically relevant antibodies with specificity to such therapeutics. We chose to evaluate well-characterized specimens from persons treated with epoetin alfa that developed antibody-mediated pure red blood cell aplasia as a means to demonstrate the utility of this platform. Our data show that this assay is capable of detecting anti-epoetin alfa antibodies with a relative antibody concentration of 50 ng/ml, where 25 of 25 sera spiked with antibodies at this concentration scored positive. Moreover, the assay was designed to include positive and negative control beads for each specimen that is processed to ensure the specificity of the signal when detected. Measurement of interassay precision supports quantitative estimates of relative antibody concentrations in the range of 313 to 5,000 ng/ml, where the percent coefficient of variation did not exceed 20%. With respect to clinical specimens, antibodies with specificity for epoetin alfa could be easily detected in a set of specimens from persons with pure red blood cell aplasia that had prior exposure to the EPREX brand of recombinant epoetin alfa. Further development and validation of this approach may facilitate successful widespread application of the method for detection of anti-epoetin alfa antibodies, as well as antibodies directed against other recombinant therapeutic proteins.
Publisher
American Society for Microbiology
Subject
Microbiology (medical),Clinical Biochemistry,Immunology,Immunology and Allergy
Reference26 articles.
1. Bennett, C. L., D. Cournoyer, K. R. Carson, J. Rossert, S. Luminari, A. M. Evens, F. Locatelli, S. M. Belknap, J. M. McKoy, E. A. Lyons, B. Kim, R. Sharma, S. Costello, E. B. Toffelmire, G. A. Wells, H. A. Messner, P. R. Yarnold, S. M. Trifilio, D. W. Raisch, T. M. Kuzel, A. Nissenson, L. C. Lim, M. S. Tallman, and N. Casadevall. 2005. Long-term outcome of individuals with pure red cell aplasia and antierythropoietin antibodies in patients treated with recombinant epoetin: a follow-up report from the Research on Adverse Drug Events and Reports (RADAR) project. Blood106:3343-3347. 2. Bonfield, T. L., N. John, B. P. Barna, M. S. Kavuru, M. J. Thomassen, and B. Yen-Lieberman. 2005. Multiplexed particle-based anti-granulocyte macrophage colony stimulating factor assay used as pulmonary diagnostic test. Clin. Diagn. Lab. Immunol.12:821-824. 3. Boven, K., J. Knight, F. Bader, J. Rossert, K. U. Eckardt, and N. Casadevall. 2005. Epoetin-associated pure red cell aplasia in patients with chronic kidney disease: solving the mystery. Nephrol. Dialysis Transplant.20:iii33-iii40. 4. Boven, K., S. Stryker, J. Knight, A. Thomas, M. van Regenmortel, D. M. Kemeny, D. Power, J. Rossert, and N. Casadevall. 2005. The increased incidence of pure red cell aplasia with an Eprex formulation in uncoated rubber stopper syringes. Kidney Int.67:2346-2353. 5. Casadevall, N., J. Nataf, B. Viron, A. Kolta, J. J. Kiladjian, P. Martin-Dupont, P. Michaud, T. Papo, V. Ugo, I. Teyssandier, B. Varet, and P. Mayeux. 2002. Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin. N. Engl. J. Med.346:469-475.
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|